InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Izzar Rachid, Responsable de la Maladie d'Alzheimer. Officer active across 1 company, notably BIOGEN INC.. In total, 19 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €256k. History available since 2 December 2021. The latest transaction was filed on 6 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Izzar Rachid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
2,044 shares0Common StockSEC:0000875045-26-000019:0
2,223 shares@ US$135.0046.8% of flowCommon StockSEC:0001127602-25-019295:0
1,515 shares0Common StockSEC:0001127602-25-004452:0
2,043 shares0Common StockSEC:0001127602-25-004243:0
1,370 shares0Common StockSEC:0001127602-24-006216:0
1,515 shares0Common StockSEC:0001127602-24-004794:0
2,043 shares0Common StockSEC:0001127602-24-004308:0
504 shares0Common StockSEC:0001127602-23-020238:0
767 shares0Common StockSEC:0001127602-23-006513:0
1,515 shares0Common StockSEC:0001127602-23-005271:0
1,783 shares0Common StockSEC:0001127602-23-002481:0
570 shares@ US$298.9044.3% of flowCommon StockSEC:0001127602-22-026993:1
189 shares@ US$298.9014.7% of flowCommon StockSEC:0001127602-22-026993:3
1,285 shares0Common StockSEC:0001127602-22-026993:0
425 shares0Common StockSEC:0001127602-22-026993:2
504 shares0Common StockSEC:0001127602-22-019020:0
594 shares0Common StockSEC:0001127602-22-006269:0
351 shares0Common StockSEC:0001127602-22-004988:0
372 shares@ US$228.5213.7% of flowCommon StockSEC:0001127602-21-030351:0
19 of 19 declarations
About Izzar Rachid
Izzar Rachid is Responsable de la Maladie d'Alzheimer and Head of Global Product Strat. at BIOGEN INC. The 19 filings recorded, all within the sampled recent filings, cover the period from 2021-12-06 to 2026-02-10. Within this sample, the buy amount is EUR 0 and the sell amount is EUR 255963, and the transaction nature is Levée d'options.
